Abstract
This article focuses on the synthesis of O6-substituted guanine derivatives and their application in medicine. O6-substituted guanines with alky-, aryl and heteroaryl-substituents and sterically challenging substituents have been described. The synthetic strategies are mainly based on different leaving groups in the 6-position of the guanine. Here, synthesis of various derivatives are described as well as the different synthetic pathways to obtain the synthetic precursors, which are prerequisites for efficient syntheses.
Keywords: substituted guanines, agt inhibitors, catalysis, rearrangement
Current Organic Synthesis
Title: Synthetic Strategies Towards O6-Substituted Guanine Derivatives and their Application in Medicine
Volume: 2 Issue: 2
Author(s): R. Schirrmacher, E. Schirrmacher, U. Mühlhausen, B. Kaina and B. Wängler
Affiliation:
Keywords: substituted guanines, agt inhibitors, catalysis, rearrangement
Abstract: This article focuses on the synthesis of O6-substituted guanine derivatives and their application in medicine. O6-substituted guanines with alky-, aryl and heteroaryl-substituents and sterically challenging substituents have been described. The synthetic strategies are mainly based on different leaving groups in the 6-position of the guanine. Here, synthesis of various derivatives are described as well as the different synthetic pathways to obtain the synthetic precursors, which are prerequisites for efficient syntheses.
Export Options
About this article
Cite this article as:
Schirrmacher R., Schirrmacher E., Mühlhausen U., Kaina B. and Wängler B., Synthetic Strategies Towards O6-Substituted Guanine Derivatives and their Application in Medicine, Current Organic Synthesis 2005; 2 (2) . https://dx.doi.org/10.2174/1570179053545369
DOI https://dx.doi.org/10.2174/1570179053545369 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Breast Cancer Chemoprevention: Current Perspectives
Current Enzyme Inhibition Personalizing Stem Cell Research and Therapy: The Arduous Road Ahead or Missed Opportunity?
Current Pharmacogenomics and Personalized Medicine Vitamin D Receptor Signaling and Pancreatic Cancer Cell EMT
Current Pharmaceutical Design Advances in Chemotherapy and Targeted Systemic Therapies for Urothelial Cancer
Current Drug Therapy Harvesting New Therapeutic Avenues with Stem Cell Applications
Current Neurovascular Research Thermosensitive Polymeric Hydrogels As Drug Delivery Systems
Current Medicinal Chemistry Targeted Drug Delivery: Trends and Perspectives
Current Drug Delivery Malignant Mesothelioma: Biology, Diagnosis and Therapeutic Approaches
Current Molecular Pharmacology Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection
Current Drug Targets Herbal Medicine for the Management of Laxative Activity
Current Pharmaceutical Biotechnology Imaging Cellular Receptors in Breast Cancers: An Overview
Current Pharmaceutical Biotechnology Current & Future Therapies of Erectile Dysfunction in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) A Knock-Down Cell-Based Study for the Functional Analysis of Chloride Intracellular Channel 1 (CLIC1): Integrated Proteomics and Microarray Study
Protein & Peptide Letters Anti-Interleukin-6 Receptor Antibody Therapy in Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Drug-Glycosidation and Drug Development
Mini-Reviews in Medicinal Chemistry Emerging Biologics in the Treatment of Inflammatory Bowel Disease: What is Around the Corner?
Current Drug Targets Personalized Therapies in Pediatric Inflammatory and Autoimmune Diseases
Current Pharmaceutical Design Editorial [Hot Topic: New Developments in Drug and Vaccine Discoveries (Executive Editor: Aldar S. Bourinbaiar)]
Current Pharmaceutical Design Lanthionine Synthetase Component C-Like Protein 2: A New Drug Target for Inflammatory Diseases and Diabetes
Current Drug Targets Dihydrofolate Reductase as a Target for Chemotherapy in Parasites
Current Pharmaceutical Design